Changes in Retinal Cell Populations after Treatment with an α7 Nicotinic Acetylcholine Receptor Agonist by Flow Cytometry

被引：0
|
作者：
Vanzo-Sparks, Hope [1 ]
Webster, Sarah [2 ]
Linn, Cindy [1 ]
机构：
[1] Western Michigan Univ, Biol Sci, Kalamazoo, MI USA
[2] Western Michigan Univ, Homer Stryker MD Sch Med, Kalamazoo, MI USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2023年 / 64卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
5458
引用
收藏
页数：2
相关论文
共 50 条
  • [1] EVIDENCE OF BrdU- POSITIVE RETINAL NEURONS AFTER APPLICATION OF AN ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONIST
    Webster, Mark K.
    Cooley-Themm, Cynthia A.
    Barnett, Joseph D.
    Bach, Harrison B.
    Vainner, Jessica M.
    Webster, Sarah E.
    Linn, Cindy L.
    NEUROSCIENCE, 2017, 346 : 437 - 446
  • [2] α7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONIST ATTENUATES NEUROPATHOLOGICAL CHANGES ASSOCIATED WITH INTRACEREBRAL HEMORRHAGE IN MICE
    Hijioka, M.
    Matsushita, H.
    Ishibashi, H.
    Hisatsune, A.
    Isohama, Y.
    Katsuki, H.
    NEUROSCIENCE, 2012, 222 : 10 - 19
  • [3] Metabolism and disposition of a selective α7 nicotinic acetylcholine receptor agonist in humans
    Shaffer, Christopher L.
    Gunduz, Mithat
    Scialis, Renato J.
    Fang, Annie F.
    DRUG METABOLISM AND DISPOSITION, 2007, 35 (07) : 1188 - 1195
  • [4] Functional Changes in the Adult Mouse Retina using an Alpha7 Nicotinic Acetylcholine Receptor Agonist after Blast Exposure
    Spitsbergen, Jake B.
    Webster, Sarah E.
    Linn, Cindy L.
    NEUROSCIENCE, 2023, 512 : 1 - 15
  • [5] Procognitive and Neuroprotective Activity of a Novel α7 Nicotinic Acetylcholine Receptor Agonist for Treatment of Neurodegenerative and Cognitive Disorders
    Roncarati, Renza
    Scali, Carla
    Comery, Thomas A.
    Grauer, Steven M.
    Aschmi, Suzan
    Bothmann, Hendrick
    Jow, Brian
    Kowal, Dianne
    Gianfriddo, Marco
    Kelley, Cody
    Zanelli, Ugo
    Ghiron, Chiara
    Haydar, Simon
    Dunlop, John
    Terstappen, Georg C.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 329 (02): : 459 - 468
  • [6] A Nicotinic Acetylcholine Receptor Agonist Prevents Loss of Retinal Ganglion Cells in a Glaucoma Model
    Iwamoto, Kazuhiro
    Birkholz, Patrick
    Schipper, Austin
    Mata, David
    Linn, David M.
    Linn, Cindy L.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (02) : 1078 - 1087
  • [7] A PHASE 2 TRIAL OF AN ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR AGONIST IN SCHIZOPHRENIA
    Freedman, Robert
    Olincy, A.
    Johnson, L.
    Buchanan, R. W.
    Kem, W. R.
    SCHIZOPHRENIA BULLETIN, 2009, 35 : 335 - 335
  • [8] α7 nicotinic acetylcholine receptor agonist properties of tilorone and related tricyclic analogues
    Briggs, C. A.
    Schrimpf, M. R.
    Anderson, D. J.
    Gubbins, E. J.
    Gronlien, J. H.
    Hakerud, M.
    Ween, H.
    Thorin-Hagene, K.
    Malysz, J.
    Li, J.
    Bunnelle, W. H.
    Gopalakrishnan, M.
    Meyer, M. D.
    BRITISH JOURNAL OF PHARMACOLOGY, 2008, 153 (05) : 1054 - 1061
  • [9] Synthesis and evaluation of a conditionally-silent agonist for the α7 nicotinic acetylcholine receptor
    Chojnacka, Kinga
    Papke, Roger L.
    Horenstein, Nicole A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (14) : 4145 - 4149
  • [10] Methadone is a Non-Competitive Antagonist at the α4β2 and α3*Nicotinic Acetylcholine Receptors and an Agonist at the α7 Nicotinic Acetylcholine Receptor
    Talka, Reeta
    Salminen, Outi
    Tuominen, Raimo K.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2015, 116 (04) : 321 - 328
12345